Published in J Neurol Neurosurg Psychiatry on January 01, 2002
Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol (2005) 1.42
The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med (2005) 1.41
Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci (2006) 1.35
Familial idiopathic basal ganglia calcification (Fahr`s disease). Neurosciences (Riyadh) (2014) 1.12
Gene, brain, and behavior relationships in fragile X syndrome: evidence from neuroimaging studies. Dev Disabil Res Rev (2009) 1.02
Fahr's disease and psychiatric syndromes: A case series. Ind Psychiatry J (2011) 1.01
Theories of impaired consciousness in epilepsy. Ann N Y Acad Sci (2009) 0.95
Sparse network-based models for patient classification using fMRI. Neuroimage (2014) 0.91
Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson's disease. J Neural Transm (Vienna) (2005) 0.89
Long-term effects of STN DBS on mood: psychosocial profiles remain stable in a 3-year follow-up. BMC Neurol (2008) 0.86
In vivo basal ganglia volumetry through application of NURBS models to MR images. Neuroradiology (2006) 0.82
Emotional blunting following left basal ganglia stroke: the role of depression and fronto-limbic functional alterations. Psychiatry Res (2012) 0.82
Quantitative analysis of motor disturbances in schizophrenic patients. Dialogues Clin Neurosci (2006) 0.81
Magnetic susceptibility of brain iron is associated with childhood spatial IQ. Neuroimage (2016) 0.80
Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls. Neuropsychologia (2012) 0.80
Semi-metric analysis of the functional brain network: Relationship with familial risk for psychotic disorder. Neuroimage Clin (2015) 0.80
Basal ganglia morphology links the metabolic syndrome and depressive symptoms. Physiol Behav (2013) 0.79
Surgical insights into Parkinson's disease. J R Soc Med (2006) 0.78
Bilateral strio-pallido-dentate calcinosis (Fahr's disease): report of seven cases and revision of literature. BMC Neurol (2016) 0.78
Pedunculopontine stimulation from primate to patient. J Neural Transm (Vienna) (2011) 0.77
A subtle mimicker in emergency department: Illustrated case reports of acute drug-induced dystonia. Medicine (Baltimore) (2016) 0.75
Developmentally Sensitive Interaction Effects of Genes and the Social Environment on Total and Subcortical Brain Volumes. PLoS One (2016) 0.75
Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology. J Neurophysiol (2016) 0.75
Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. Neuropsychiatr Dis Treat (2016) 0.75
Imaging analysis of Parkinson's disease patients using SPECT and tractography. Sci Rep (2016) 0.75
Correlation of Tc-99 m ethyl cysteinate dimer single-photon emission computed tomography and clinical presentations in patients with low cobalamin status. BMC Neurol (2015) 0.75
Risperidone-induced Enuresis in a 12-year-old Child. J Neurosci Rural Pract (2017) 0.75
Parkinson's disease and primate research: past, present, and future. Postgrad Med J (2006) 0.75
Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17
Drug abuse: hedonic homeostatic dysregulation. Science (1997) 8.22
Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) (1999) 7.06
Huntington disease. J Neuropathol Exp Neurol (1998) 6.54
Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res (1990) 5.79
From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol (1980) 5.46
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex (2000) 4.61
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology (1990) 4.41
Depression and Parkinson's disease: a review. Am J Psychiatry (1992) 4.36
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry (2000) 3.89
The anatomy of mood disorders--review of structural neuroimaging studies. Biol Psychiatry (1997) 2.86
Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann N Y Acad Sci (1999) 2.86
Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci (1990) 2.83
Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. Science (1994) 2.70
Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci (1999) 2.52
Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry (1984) 2.31
Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet (1999) 2.30
Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1998) 2.28
The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience (2000) 2.25
Tourette syndrome, associated conditions and the complexities of treatment. Brain (2000) 2.09
The current model of basal ganglia organization under scrutiny. Mov Disord (1998) 2.08
Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 2.07
Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry (2001) 2.04
The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci (1997) 2.00
A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1992) 1.93
Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J Neuropsychiatry Clin Neurosci (1999) 1.90
Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry (1996) 1.85
An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry (1999) 1.82
Cortical magnetic resonance imaging changes in elderly inpatients with major depression. Am J Psychiatry (1991) 1.78
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
Antecedent clinical features associated with dementia in Parkinson's disease. Neurology (1993) 1.74
Psychopathological alterations in cases of symmetrical basal ganglia sclerosis. Biol Psychiatry (1989) 1.71
Regional brain enlargement in autism: a magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry (1996) 1.70
Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry (1995) 1.67
The association of affective disorder with Huntington's disease in a case series and in families. Psychol Med (1983) 1.65
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease. Neurology (1996) 1.57
Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology (1999) 1.55
Prevalence and natural history of progressive supranuclear palsy. Neurology (1988) 1.54
Sex of parent transmission effect in Tourette's syndrome: evidence for earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect. Neurology (1997) 1.54
The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol (1995) 1.51
Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry (1993) 1.51
Crime in Huntington's disease: a study of registered offences among patients, relatives, and controls. J Neurol Neurosurg Psychiatry (1998) 1.49
Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychol Med (1997) 1.48
Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.47
Psychiatric symptoms in Parkinsonism. J Neurol Neurosurg Psychiatry (1970) 1.45
The role of the striatopallidal and extended amygdala systems in drug addiction. Ann N Y Acad Sci (1999) 1.44
Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog Neurobiol (2000) 1.44
Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study. Brain (1987) 1.44
Neuropsychiatry of Huntington's disease and other basal ganglia disorders. Psychosomatics (2000) 1.43
Basal ganglia regional glucose metabolism asymmetry during a catatonic episode. Biol Psychiatry (1989) 1.38
Psychiatric and behavioral abnormalities in Wilson's disease. Adv Neurol (1995) 1.31
Wilson's disease. Psychiatric symptoms in 195 cases. Arch Gen Psychiatry (1989) 1.31
Frequency of dementia in Parkinson disease. Arch Neurol (1996) 1.30
Depression in Parkinson's disease. J Nerv Ment Dis (1990) 1.29
Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol (1989) 1.27
Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr Res (1995) 1.26
The neuropsychology of Parkinson's disease. Brain Cogn (1995) 1.25
Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther (1994) 1.23
Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol (1993) 1.23
Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry (1995) 1.21
Cognitive impairments and depression in Parkinson's disease: a follow up study. J Neurol Neurosurg Psychiatry (1990) 1.19
Haplotype and mutation analysis in Japanese patients with Wilson disease. Am J Hum Genet (1997) 1.17
Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology (1992) 1.14
Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science (1996) 1.13
Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J Nerv Ment Dis (1998) 1.12
Parkinson's disease and depression. A critical re-evaluation. Brain (1986) 1.10
Depression in patients with Parkinson's disease. Int J Geriatr Psychiatry (1999) 1.09
Huntington disease in Maryland: clinical aspects of racial variation. Am J Hum Genet (1987) 1.07
Psychiatric morbidity in patients with Parkinson's disease. Psychol Med (1990) 1.07
Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease. Neurology (1998) 1.05
Striatal dopamine transporter density in major depression. Psychopharmacology (Berl) (1999) 1.03
[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry (1995) 1.03
Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res (1992) 1.01
Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol (1997) 1.01
Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology? Clin Psychol Rev (1999) 1.00
Risk factors for dementia in Parkinson's disease: effect of education. Neuroepidemiology (1996) 1.00
Frontostriatal deficits in unipolar major depression. Brain Res Bull (1998) 0.99
Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol (1991) 0.98
Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry (1982) 0.98
The epidemiology of Parkinson's disease. Baillieres Clin Neurol (1997) 0.97
Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease. Arch Gen Psychiatry (1992) 0.97
Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation. Neurology (1997) 0.95
Annotation: Gilles de la Tourette syndrome--an update. J Child Psychol Psychiatry (1994) 0.95
The pathomorphology of schizophrenia and mood disorders: similarities and differences. Schizophr Res (1999) 0.94
Depression in Parkinson's disease: a biochemical and organic viewpoint. Adv Neurol (1995) 0.93
Obsessive-compulsive disorder in Huntington's disease. Biol Psychiatry (1992) 0.92
Psychiatric side effects of levodopa in man. JAMA (1971) 0.91
Dementia in Parkinson's disease. Arch Neurol (1986) 0.90
Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci (2000) 0.89
Depression in Parkinson's disease. BMJ (2000) 0.89
Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice. Psychiatr Clin North Am (1997) 0.88
PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. J Neurol Neurosurg Psychiatry (1994) 0.87
Schizophrenia, psychosis, and the basal ganglia. Psychiatr Clin North Am (1997) 0.86
Kindling of the mesolimbic dopamine system: animal model of psychosis. Neurology (1978) 0.86
Psychosis and other psychiatric manifestations of levodopa therapy. Arch Neurol (1970) 0.86
D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics. Ann N Y Acad Sci (1999) 0.86
New concepts about the organization of basal ganglia output. Adv Neurol (1997) 0.86
Tic disorders: new developments in Tourette syndrome and related disorders. Curr Opin Neurol (1998) 0.84
Identification of the neural systems subserving the actions of clozapine: clues from immediate-early gene expression. J Clin Psychiatry (1994) 0.84
Early diagnosis of the frontal variant of frontotemporal dementia: how sensitive are standard neuroimaging and neuropsychologic tests? Neuropsychiatry Neuropsychol Behav Neurol (1999) 0.93
Palicoprolalia: an unusual variant of palilalia in Gilles de la Tourette's syndrome. J Neuropsychiatry Clin Neurosci (1998) 0.76
Epidemiology of vascular dementia. Br J Psychiatry (1993) 0.75
Antiphospholipid antibodies and Binswanger's disease. Neurology (1996) 0.75
[The rebirth of psychiatry]. Neurologia (1993) 0.75
[Binswanger disease and antiphospholipid antibodies]. Neurologia (1992) 0.75
[Medical treatment of Alzheimer's disease]. Rev Neurol (1998) 0.75
[Pick disease]. Rev Neurol (Paris) (1992) 0.75
Treatment of palilalia with trazodone. Am J Psychiatry (1996) 0.75
[The inclusion of the family in the therapeutic process in dementia]. Neurologia (1992) 0.75
[Integrated program of psychogeriatric care]. Rev Neurol (2000) 0.75